Product Introduction
Bioactivity


英文名: Altiratinib

描述: Altiratinib (DCC-2701) 是一种多靶点激酶抑制剂，能够抑制 MET (IC50:2.7 nM)，TIE2 (IC50:8 nM)，VEGFR2 (IC50:9.2 nM)，FLT3 (IC50:9.3 nM)，Trk1 (IC50:0.85 nM)，Trk2 (IC50:4.6 nM) 和 Trk3 (IC50:0.83 nM)。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 45 mg/mL (88.15 mM)


关键字: Cluster of differentiation antigen 135 | c-Met/HGFR | Trk Receptor | Inhibitor | CD135 | inhibit | Altiratinib | FLT3 | Vascular endothelial growth factor receptor | Tropomyosin related kinase receptor | DCC 2701 | VEGFR | DCC2701 | Fms like tyrosine kinase 3

相关产品: VEGFR-2/c-Met-IN-1 | Tanshinone IIA | BMS-605541 | AZD4547 | Chloropyramine hydrochloride | GW806742X | SAR131675 | BMS-794833 | VEGFR2/HDAC1-IN-1 | TG 100572

相关库: Drug Repurposing Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Fluorochemical Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Kinase Inhibitor Library | Anti-Colorectal Cancer Compound Library | Anti-Cancer Active Compound Library | Tyrosine Kinase Inhibitor Library